BTAI - BioXcel Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
0
0
0
0
0
Operating Expense
41,178
33,601
19,962
4,537
2,120
Operating Income
-41,178
-33,601
-19,962
-4,537
-2,120
Net Non Operating Interest Income Expense
-
-
692
-2
0
Other Income Expense
503
633
692
-
-
Pretax Income
-40,675
-32,968
-19,270
-4,539
-2,120
Net Income Common Stockholders
-40,675
-32,968
-19,270
-4,539
-2,120
Diluted NI Available to Com Stockholders
-40,675
-32,968
-19,270
-4,539
-2,120
Basic EPS
-
-0.002
-0.0013
0
0
Diluted EPS
-
-0.002
-0.0013
0
0
Basic Average Shares
-
16,289
14,572
15,646
15,646
Diluted Average Shares
-
16,289
14,572
15,646
15,646
Total Operating Income as Reported
-41,178
-33,601
-19,962
-4,537
-2,120
Total Expenses
41,178
33,601
19,962
4,537
2,120
Net Income from Continuing & Discontinued Operation
-40,675
-32,968
-19,270
-4,539
-2,120
Normalized Income
-41,178
-33,601
-19,962
-4,539
-2,120
Interest Expense
-
-
-
2
0
Net Interest Income
-
-
692
-2
0
EBIT
-41,178
-33,601
-19,962
-4,537
-2,120
EBITDA
-41,012
-
-
-
-
Reconciled Depreciation
166
156
17
1
0
Net Income from Continuing Operation Net Minority Interest
-40,675
-32,968
-19,270
-4,539
-2,120
Total Unusual Items Excluding Goodwill
503
633
692
-
-
Total Unusual Items
503
633
692
-
-
Normalized EBITDA
-41,515
-34,078
-20,637
-4,536
-2,120
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0